Cargando…

Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort

AIMS/HYPOTHESIS: Accumulated data suggest that infections in early life contribute to the development of type 1 diabetes. Using data from the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), we set out to assess whether children who later developed diabetes-related autoantibodies and/or clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordonouri, Olga, Cuthbertson, David, Belteky, Malin, Aschemeier-Fuchs, Bärbel, White, Neil H., Cummings, Elisabeth, Knip, Mikael, Ludvigsson, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630400/
https://www.ncbi.nlm.nih.gov/pubmed/36083343
http://dx.doi.org/10.1007/s00125-022-05786-3
_version_ 1784823594125099008
author Kordonouri, Olga
Cuthbertson, David
Belteky, Malin
Aschemeier-Fuchs, Bärbel
White, Neil H.
Cummings, Elisabeth
Knip, Mikael
Ludvigsson, Johnny
author_facet Kordonouri, Olga
Cuthbertson, David
Belteky, Malin
Aschemeier-Fuchs, Bärbel
White, Neil H.
Cummings, Elisabeth
Knip, Mikael
Ludvigsson, Johnny
author_sort Kordonouri, Olga
collection PubMed
description AIMS/HYPOTHESIS: Accumulated data suggest that infections in early life contribute to the development of type 1 diabetes. Using data from the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), we set out to assess whether children who later developed diabetes-related autoantibodies and/or clinical type 1 diabetes had different exposure to infections early in life compared with those who did not. METHODS: A cohort of 2159 children with an affected first-degree relative and HLA-conferred susceptibility to type 1 diabetes were recruited between 2002 and 2007 and followed until 2017. Infections were registered prospectively. The relationship between infections in the first year of life and the development of autoantibodies or clinical type 1 diabetes was analysed using univariable and multivariable Cox regression models. As this study was exploratory, no adjustment was made for multiple comparisons. RESULTS: Adjusting for HLA, sex, breastfeeding duration and birth order, those who had seven or more infections during their first year of life were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.028, HR 9.166 [95% CI 1.277, 65.81]) compared with those who had no infections. Those who had their first viral infection aged between 6 and 12 months were less likely to develop at least one positive type 1 diabetes-related antibody (p=0.043, HR 0.828 [95% CI 0.690, 0.994]) or multiple antibodies (p=0.0351, HR 0.664 [95% CI 0.453, 0.972]). Those who had ever had an unspecified bacterial infection were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.013, HR 1.412 [95% CI 1.075, 1.854]), to develop multiple antibodies (p=0.037, HR 1.652 [95% CI 1.030, 2.649]) and to develop clinical type 1 diabetes (p=0.011, HR 2.066 [95% CI 1.182, 3.613]). CONCLUSIONS/INTERPRETATION: We found weak support for the assumption that viral infections early in life may initiate the autoimmune process or later development of type 1 diabetes. In contrast, certain bacterial infections appeared to increase the risk of both multiple autoantibodies and clinical type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05786-3) contains peer-reviewed but unedited supplementary material.
format Online
Article
Text
id pubmed-9630400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96304002022-11-04 Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort Kordonouri, Olga Cuthbertson, David Belteky, Malin Aschemeier-Fuchs, Bärbel White, Neil H. Cummings, Elisabeth Knip, Mikael Ludvigsson, Johnny Diabetologia Article AIMS/HYPOTHESIS: Accumulated data suggest that infections in early life contribute to the development of type 1 diabetes. Using data from the Trial to Reduce IDDM in the Genetically at Risk (TRIGR), we set out to assess whether children who later developed diabetes-related autoantibodies and/or clinical type 1 diabetes had different exposure to infections early in life compared with those who did not. METHODS: A cohort of 2159 children with an affected first-degree relative and HLA-conferred susceptibility to type 1 diabetes were recruited between 2002 and 2007 and followed until 2017. Infections were registered prospectively. The relationship between infections in the first year of life and the development of autoantibodies or clinical type 1 diabetes was analysed using univariable and multivariable Cox regression models. As this study was exploratory, no adjustment was made for multiple comparisons. RESULTS: Adjusting for HLA, sex, breastfeeding duration and birth order, those who had seven or more infections during their first year of life were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.028, HR 9.166 [95% CI 1.277, 65.81]) compared with those who had no infections. Those who had their first viral infection aged between 6 and 12 months were less likely to develop at least one positive type 1 diabetes-related antibody (p=0.043, HR 0.828 [95% CI 0.690, 0.994]) or multiple antibodies (p=0.0351, HR 0.664 [95% CI 0.453, 0.972]). Those who had ever had an unspecified bacterial infection were more likely to develop at least one positive type 1 diabetes-related autoantibody (p=0.013, HR 1.412 [95% CI 1.075, 1.854]), to develop multiple antibodies (p=0.037, HR 1.652 [95% CI 1.030, 2.649]) and to develop clinical type 1 diabetes (p=0.011, HR 2.066 [95% CI 1.182, 3.613]). CONCLUSIONS/INTERPRETATION: We found weak support for the assumption that viral infections early in life may initiate the autoimmune process or later development of type 1 diabetes. In contrast, certain bacterial infections appeared to increase the risk of both multiple autoantibodies and clinical type 1 diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-022-05786-3) contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2022-09-09 2022 /pmc/articles/PMC9630400/ /pubmed/36083343 http://dx.doi.org/10.1007/s00125-022-05786-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kordonouri, Olga
Cuthbertson, David
Belteky, Malin
Aschemeier-Fuchs, Bärbel
White, Neil H.
Cummings, Elisabeth
Knip, Mikael
Ludvigsson, Johnny
Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title_full Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title_fullStr Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title_full_unstemmed Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title_short Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort
title_sort infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the trigr cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630400/
https://www.ncbi.nlm.nih.gov/pubmed/36083343
http://dx.doi.org/10.1007/s00125-022-05786-3
work_keys_str_mv AT kordonouriolga infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT cuthbertsondavid infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT beltekymalin infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT aschemeierfuchsbarbel infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT whiteneilh infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT cummingselisabeth infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT knipmikael infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort
AT ludvigssonjohnny infectionsinthefirstyearoflifeanddevelopmentofbetacellautoimmunityandclinicaltype1diabetesinhighriskindividualsthetrigrcohort